Competitive Generic Therapies (CGT) - 180-Day Exclusivity

CGT 180-Day Exclusivity including
Introduntion to Competetive Generic Therapies
FDA Reauthorisation Act 2017
CGT 180-Day exclusivity
Inadequate Generic Competition determination criteria
Orange book data
Application for CGT designation
CGT designation by FDA
Relinquishment or waiver of CGT exclusivity
CGT designation determination by FDA within 60 days

#education
#training
#patent
#pharma
#industry
#regulatory
#intellectual
#intellectualproperty
#pharmaceutical

Disclaimer: This channel is for information purposes only for providing information on various topics related to pharma industry. The information in this channel is for education and information purposes only and should not be considered as any legal advice. One should always take legal advice before acting. This channel is not responsible for any loss or harm including monetary loss or any other type of loss or harm to any one based on actions taken on basis of this information or because of information given in this channel.